AU2003242324A1 - Verotoxin production inhibitor - Google Patents
Verotoxin production inhibitorInfo
- Publication number
- AU2003242324A1 AU2003242324A1 AU2003242324A AU2003242324A AU2003242324A1 AU 2003242324 A1 AU2003242324 A1 AU 2003242324A1 AU 2003242324 A AU2003242324 A AU 2003242324A AU 2003242324 A AU2003242324 A AU 2003242324A AU 2003242324 A1 AU2003242324 A1 AU 2003242324A1
- Authority
- AU
- Australia
- Prior art keywords
- production inhibitor
- verotoxin
- verotoxin production
- inhibitor
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-172339 | 2002-06-13 | ||
JP2002172339 | 2002-06-13 | ||
PCT/JP2003/007479 WO2003105870A1 (ja) | 2002-06-13 | 2003-06-12 | ベロ毒素産生抑制剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003242324A1 true AU2003242324A1 (en) | 2003-12-31 |
Family
ID=29727862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003242324A Abandoned AU2003242324A1 (en) | 2002-06-13 | 2003-06-12 | Verotoxin production inhibitor |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPWO2003105870A1 (ja) |
AU (1) | AU2003242324A1 (ja) |
TW (1) | TW200400827A (ja) |
WO (1) | WO2003105870A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6075015B2 (ja) * | 2011-11-14 | 2017-02-08 | 東レ・オペロンテックス株式会社 | ポリウレタン弾性繊維およびその製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998022115A1 (fr) * | 1996-11-22 | 1998-05-28 | Taisho Pharmaceutical Co., Ltd. | Agent therapeutique contre les infections a escherichia coli enterohemorragique |
JPH10265394A (ja) * | 1997-03-27 | 1998-10-06 | Wakamoto Pharmaceut Co Ltd | 腸管出血性大腸菌感染症予防又は治療剤 |
JPH1143443A (ja) * | 1997-05-27 | 1999-02-16 | Naohiko Sato | 食中毒菌に対する選択的殺菌剤 |
AUPP059897A0 (en) * | 1997-11-27 | 1998-01-08 | Fujisawa Pharmaceutical Co., Ltd. | New use of bicozamycin |
EP1219616A4 (en) * | 1999-09-20 | 2002-11-06 | Amato Pharm Prod Ltd | PROCESS FOR THE PREPARATION OF CYCLIC LACTIC ACID OLIGOMERS |
EP1224936A1 (en) * | 1999-09-20 | 2002-07-24 | Amato Pharmaceutical Products, Ltd. | Physical strength enhancing agents and glycogen accumulation promoting agents |
JP2002275256A (ja) * | 2001-03-19 | 2002-09-25 | Tendou Seiyaku Kk | 乳酸オリゴマーの製造方法 |
-
2003
- 2003-06-12 AU AU2003242324A patent/AU2003242324A1/en not_active Abandoned
- 2003-06-12 WO PCT/JP2003/007479 patent/WO2003105870A1/ja active Application Filing
- 2003-06-12 JP JP2004512772A patent/JPWO2003105870A1/ja active Pending
- 2003-06-12 TW TW092116002A patent/TW200400827A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003105870A1 (ja) | 2003-12-24 |
JPWO2003105870A1 (ja) | 2005-10-27 |
TW200400827A (en) | 2004-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003202263A1 (en) | Roh-kinase inhibitors | |
AU2003902828A0 (en) | Dpp-iv inhibitor | |
AU2003902946A0 (en) | Dpp-iv inhibitor | |
AU2003303483A1 (en) | Ccr8 inhibitors | |
AU2003900608A0 (en) | Hdac inhibitor | |
AU2003902260A0 (en) | Dpp-iv inhibitor | |
AU2003224111A1 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
WO2003072535A8 (en) | Substituted hydroxyethylamines | |
AU2003238043A1 (en) | Substituted imidazotriazines | |
AU2003245984A1 (en) | Hetero-cyclicaly substituted imidazotriazines | |
AU2003299883A1 (en) | Ccr8 inhibitors | |
AU2003249683A1 (en) | Nf-:b inhibitors | |
AU2002952946A0 (en) | Dpp-iv inhibitor | |
AU2003238042A1 (en) | Cyclooxygenase-2 inhibitors | |
AU2003233426A1 (en) | Corrosion inhibitor | |
AU2003244750A1 (en) | Polymerisation inhibitor | |
AU2003278355A1 (en) | Process | |
AU2003294900A1 (en) | Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides | |
AU2003212366A1 (en) | Substituted 4-aminocyclohexanols | |
AU2003256323A1 (en) | Sos1 inhibitors | |
AU2003242559A1 (en) | Alkylaminosiloxanes as corrosion inhibitors | |
AU2003282700A1 (en) | Kavalactone product | |
AU2003262681A1 (en) | Hemo-aide | |
AU2003242324A1 (en) | Verotoxin production inhibitor | |
AU2003900587A0 (en) | Hdac inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |